|
1
|
Kim MH, Jung SY, Song KH, Park JI, Ahn J,
Kim EH, Park JK, Hwang SG, Woo HJ and Song JY: A new FGFR inhibitor
disrupts the TGF-β1-induced fibrotic process. J Cell Mol Med.
24:830–840. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barratt SL, Creamer A, Hayton C and
Chaudhuri N: Idiopathic pulmonary fibrosis (IPF): An overview. J
Clin Med. 7:2012018. View Article : Google Scholar
|
|
3
|
Selman M, King TE and Pardo A: Idiopathic
pulmonary fibrosis: Prevailing and evolving hypotheses about its
pathogenesis and implications for therapy. Ann Internal Med.
134:136–151. 2001. View Article : Google Scholar
|
|
4
|
Kim KK, Kugler MC, Wolters PJ, Robillard
L, Galvez MG, Brumwell AN, Sheppard D and Chapman HA: Alveolar
epithelial cell mesenchymal transition develops in vivo during
pulmonary fibrosis and is regulated by the extracellular matrix.
Proc Natl Acad Sci USA. 103:13180–13185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Willis BC, Liebler JM, Luby-Phelps K,
Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of
epithelial-mesenchymal transition in alveolar epithelial cells by
transforming growth factor-beta1: Potential role in idiopathic
pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pardali E, Sanchez-Duffhues G,
Gomez-Puerto MC and Ten Dijke P: TGF-β-induced
endothelial-mesenchymal transition in fibrotic diseases. Int J Mol
Sci. 18:21572017. View Article : Google Scholar
|
|
7
|
Aquino-Jarquin G: Emerging role of
CRISPR/Cas9 technology for MicroRNAs editing in cancer research.
Cancer Res. 77:6812–6817. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gai YP, Zhao HN, Zhao YN, Zhu BS, Yuan SS,
Li S, Guo FY and Ji XL: MiRNA-seq-based profiles of miRNAs in
mulberry phloem sap provide insight into the pathogenic mechanisms
of mulberry yellow dwarf disease. Sci Rep. 8:8122018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Ann Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar
|
|
10
|
Aljagthmi AA, Hill NT, Cooke M, Kazanietz
MG, Abba MC, Long W and Kadakia MP: ΔNp63α suppresses cells
invasion by downregulating PKCγ/Rac1 signaling through miR-320a.
Cell Death Dis. 10:6802019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang HH, Li R, Li YJ, Yu XX, Sun QN, Li
AY and Kong Y: eIF4E-related miR-320a and miR-340-5p inhibit
endometrial carcinoma cell metastatic capability by preventing
TGF-β1-induced epithelial-mesenchymal transition. Oncol Rep.
43:447–460. 2020.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Waters DW, Blokland KEC, Pathinayake PS,
Burgess JK, Mutsaers SE, Prele CM, Schuliga M, Grainge CL and
Knight DA: Fibroblast senescence in the pathology of idiopathic
pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol.
315:L162–l172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang C, Xiao X, Yang Y, Mishra A, Liang
Y, Zeng X, Yang X, Xu D, Blackburn MR, Henke CA and Liu L:
MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast
proliferation and activation. J Biol Chem. 292:16420–16439. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Liang Y, Luo J, Nie J, Yin H, Chen
Q, Dong J, Zhu J, Xia J and Shuai W: XIST/miR-139 axis regulates
bleomycin (BLM)-induced extracellular matrix (ECM) and pulmonary
fibrosis through β-catenin. Oncotarget. 8:65359–65369. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang ZC, Qu ZH, Yi MJ, Shan YC, Ran N, Xu
L and Liu XJ: MiR-448-5p inhibits TGF-β1-induced
epithelial-mesenchymal transition and pulmonary fibrosis by
targeting Six1 in asthma. J Cell Physiol. 234:8804–8814. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foster KA, Oster CG, Mayer MM, Avery ML
and Audus KL: Characterization of the A549 cell line as a type II
pulmonary epithelial cell model for drug metabolism. Exp Cell Res.
243:359–366. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lieber M, Smith B, Szakal A, Nelson-Rees W
and Todaro G: A continuous tumor-cell line from a human lung
carcinoma with properties of type II alveolar epithelial cells. Int
J Cancer. 17:62–70. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levy DE and Darnell JE Jr: Stats:
Transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pedroza M, Le TT, Lewis K,
Karmouty-Quintana H, To S, George AT, Blackburn MR, Tweardy DJ and
Agarwal SK: STAT-3 contributes to pulmonary fibrosis through
epithelial injury and fibroblast-myofibroblast differentiation.
FASEB J. 30:129–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai B, Cui M, Zhu M, Su WL, Qiu MC and
Zhang H: STAT1/3 and ERK1/2 synergistically regulate cardiac
fibrosis induced by high glucose. Cell Physiol Biochem. 32:960–971.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogata H, Chinen T, Yoshida T, Kinjyo I,
Takaesu G, Shiraishi H, Iida M, Kobayashi T and Yoshimura A: Loss
of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated
TGF-beta1 production. Oncogene. 25:2520–2530. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shigekawa M, Takehara T, Kodama T, Hikita
H, Shimizu S, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, et al:
Involvement of STAT3-regulated hepatic soluble factors in
attenuation of stellate cell activity and liver fibrogenesis in
mice. Biochem Biophys Res Commun. 406:614–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Le TT, Karmouty-Quintana H, Melicoff E, Le
TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, et al:
Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J
Immunol. 193:3755–3768. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zehender A, Huang J, Györfi AH, Matei AE,
Trinh-Minh T, Xu X, Li YN, Chen CW, Lin J, Dees C, et al: The
tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to
regulate fibroblast activation and fibrosis. Nat Commun.
9:32592018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Q, Liu Y, Pan H, Xu T, Li Y, Yuan J, Li
P, Yao W, Yan W and Ni C: Aberrant expression of miR-125a-3p
promotes fibroblast activation via Fyn/STAT3 pathway during
silica-induced pulmonary fibrosis. Toxicology. 414:57–67. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morikawa M, Derynck R and Miyazono K:
TGF-β and the TGF-β family: Context-dependent roles in cell and
tissue physiology. Cold Spring Harbor Perspect Biol. 8:a0218732016.
View Article : Google Scholar
|
|
28
|
Ask K, Bonniaud P, Maass K, Eickelberg O,
Margetts PJ, Warburton D, Groffen J, Gauldie J and Kolb M:
Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1
but not TGF-beta3. Int J Biochem Cell Biol. 40:484–495. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Border WA and Noble NA: Transforming
growth factor beta in tissue fibrosis. N Engl J Med. 331:1286–1292.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wynn TA and Ramalingam TR: Mechanisms of
fibrosis: Therapeutic translation for fibrotic disease. Nat Med.
18:1028–1040. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng XH and Derynck R: Specificity and
versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev
Biol. 21:659–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walton KL, Johnson KE and Harrison CA:
Targeting TGF-β mediated SMAD signaling for the prevention of
fibrosis. Front Pharmacol. 8:4612017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang LY, Heller M, Meng Z, Yu LR, Tang Y,
Zhou M and Zhang YE: Transforming Growth Factor-β (TGF-β) directly
activates the JAK1-STAT3 axis to induce hepatic fibrosis in
coordination with the SMAD pathway. J Biol Chem. 292:4302–4312.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan
L, Lin X and Feng XH: STAT3 selectively interacts with Smad3 to
antagonize TGF-β signalling. Oncogene. 35:4388–4398. 2016.
View Article : Google Scholar : PubMed/NCBI
|
